ERG and cancer: In cholangiocarcinoma, lncRNA SNHG3 can competitively adsorb miR-3173-5p (a tumour suppressor miRNA), release its inhibitory effect on the oncogene ERG, and promote the malignant phenotype of cancer cells [57].